Download PDF

Other users also viewed these articles

Effect of elexacaftor–tezacaftor–ivacaftor modulator on lung structure in cystic fibrosis V. Fainardi, K. Skenderaj, A. Ciuni, S. Esposito, N. Sverzellati, G. Pisi
10.1016/j.pulmoe.2022.11.007
A real-life study of elexacaftor-tezacaftor-ivacaftor therapy in people with cystic fibrosis in Brazil L.Z. Salomão, R.A. Athanazio, S.Z. Rached, M. Lopes-Pacheco, M. Camargo
10.1016/j.pulmoe.2023.03.008
Changes in exercise endurance and inspiratory capacity after lumacaftor/ivacaftor therapy in cystic fibrosis D. Savi, A. Gramegna, M. Vicenzi, M. Di Paolo, B. Messore, P. Palange, F. Blasi
10.1016/j.pulmoe.2022.09.009